Nipride is Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL solution) supplied in a sterile, single-use 2 mL vial. This intravenous solution is intended for use as a vasodilator as described in the product labeling. Manufactured by Pfizer Canada, it carries DIN 02361736. Prescription status: Not required in Canada; required in Quebec.